Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo
Saved in:
| Published in: | Bioengineering & Translational Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553682421809153 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Bioengineering & Translational Medicine |
| description | |
| discipline_display | Bioengineering |
| discipline_facet | Bioengineering |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:82648 |
| institution | FRELIP |
| journal_source_facet | Bioengineering & Translational Medicine |
| last_indexed | 2026-06-20T21:40:52.349Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo Bioengineering General Bioengineering |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Bioengineering General Bioengineering |
| subject_facet | Bioengineering General Bioengineering |
| title | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_alt | Timosina β4 pegilada es un profármaco específico de sitio tiol que trata el infarto de miocardio in vivo Thymosine β4 PEGylée est un promédicament spécifique au site thiol traitant l'infarctus du myocarde in vivo Timosina β4 PEGuilada é um pró-fármaco específico do sítio tiol para tratar infarto do miocárdio in vivo |
| title_auth | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_es_txt | Timosina β4 pegilada es un profármaco específico de sitio tiol que trata el infarto de miocardio in vivo |
| title_fr_txt | Thymosine β4 PEGylée est un promédicament spécifique au site thiol traitant l'infarctus du myocarde in vivo |
| title_full | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_fullStr | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_full_unstemmed | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_pt_txt | Timosina β4 PEGuilada é um pró-fármaco específico do sítio tiol para tratar infarto do miocárdio in vivo |
| title_short | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| title_sort | pegylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo |
| topic | Bioengineering General Bioengineering |
| url | https://aiche.onlinelibrary.wiley.com/doi/10.1002/btm2.70144?af=R |